Drug
Calaspargase Pegol
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Anaphylactic Reaction | 98 | 50.3 | 57.8 | signal |
| 2 | Pancreatitis | 71 | 37.8 | 41.7 | signal |
| 3 | Hypersensitivity | 204 | 31.0 | 42.3 | signal |
| 4 | Infusion Related Reaction | 67 | 28.6 | 31.3 | signal |
| 5 | Electrolyte Imbalance | 11 | 26.9 | 27.3 | signal |
| 6 | Polyneuropathy | 11 | 26.0 | 26.4 | signal |
| 7 | Coagulopathy | 15 | 25.4 | 25.9 | signal |
| 8 | Eyelid Ptosis | 9 | 24.9 | 25.2 | signal |
| 9 | Febrile Neutropenia | 52 | 22.1 | 23.7 | signal |
| 10 | Hepatotoxicity | 17 | 21.6 | 22.1 | signal |
| 11 | Pancreatitis Acute | 15 | 18.9 | 19.3 | signal |
| 12 | Circulatory Collapse | 11 | 18.1 | 18.4 | signal |
| 13 | Hyperbilirubinaemia | 6 | 16.4 | 16.5 | signal |
| 14 | Hyperglycaemia | 21 | 16.3 | 16.7 | signal |
| 15 | Clostridium Difficile Infection | 11 | 14.3 | 14.5 | signal |
| 16 | Drug Level Decreased | 5 | 13.8 | 13.9 | signal |
| 17 | Acute Hepatic Failure | 6 | 12.4 | 12.5 | signal |
| 18 | Drug Level Increased | 7 | 11.9 | 12.0 | signal |
| 19 | Neurotoxicity | 7 | 11.3 | 11.4 | signal |